Hemedex

Hemedex is a medical technology company that specializes in the development and commercialization of real-time, continuous tissue perfusion monitoring systems. The company's flagship product, the Bowman Perfusion Monitor (BPM), utilizes proprietary thermal diffusion flowmetry to provide clinicians with quantified measurements of local tissue blood flow. This technology is primarily used in neurocritical care to monitor patients with traumatic brain injury or subarachnoid hemorrhage, as well as in applications involving organ transplantation and reconstructive surgery. By providing immediate feedback on tissue viability, Hemedex's solutions aim to improve patient outcomes through early detection of ischemia. The company's technology originated from research conducted at the Massachusetts Institute of Technology.